Solvotrin Therapeutics Ltd is an Irish owned privately held pharmaceutical company based in Cork. Solvotrin is committed to developing cutting edge science to address unmet needs.
Solvotrin Therapeutics is dedicated to sound scientific research. Active Iron is clinically proven to have twice the absorption of the gold-standard iron sulfate.
Solvotrin Therapeutics is a privately held Irish healthcare and medicine development company. Our vision is to utilize innovative science to create products that deliver on significant unmet clinical needs. Our development is focused on optimizing established therapies to bring a significant improvement in clinical outcomes and ultimately improve the quality of life for patients across the world.
Solvotrin Therapeutics was incorporated and established in 2009 after the discovery of a platform of salicylate and niacin pro-drugs, which are backed by a family of granted and pending patents.
Solvotrin launched its first product Active Iron in 2016. This iron product was developed together with scientists at Trinity College Dublin. The groundbreaking formulation uses an innovative method of delivering iron which improves absorption and reduces side-effects.
Our research and development programmes are currently focused on pro-drugs in inflammatory skin diseases and oncology along with further expansion of the Active Iron range.